Last reviewed · How we verify
Zidovudine, Stavudine, Didanosine, Lamivudine
Zidovudine, Stavudine, Didanosine, Lamivudine is a Small molecule drug developed by The HIV Netherlands Australia Thailand Research Collaboration. It is currently in Phase 2 development.
At a glance
| Generic name | Zidovudine, Stavudine, Didanosine, Lamivudine |
|---|---|
| Sponsor | The HIV Netherlands Australia Thailand Research Collaboration |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIV (PHASE2, PHASE3)
- A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments (PHASE4)
- A Prospective Cohort of Children With HIV Infection
- Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone (PHASE3)
- Preventing Sexual Transmission of HIV With Anti-HIV Drugs (PHASE3)
- Immunologic and Virologic Consequences of Long-Term Highly Active Antiretroviral Therapy (HAART) in Subjects With Moderately Advanced HIV-1 Disease: A Follow-Up Study to ACTG 315 (PHASE2)
- Virologic Responses To New Nucleoside Regimens After Prolonged ZDV or ddI Monotherapy (PHASE2)
- Antiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine, Stavudine, or Didanosine (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Zidovudine, Stavudine, Didanosine, Lamivudine CI brief — competitive landscape report
- Zidovudine, Stavudine, Didanosine, Lamivudine updates RSS · CI watch RSS
- The HIV Netherlands Australia Thailand Research Collaboration portfolio CI
Frequently asked questions about Zidovudine, Stavudine, Didanosine, Lamivudine
What is Zidovudine, Stavudine, Didanosine, Lamivudine?
Zidovudine, Stavudine, Didanosine, Lamivudine is a Small molecule drug developed by The HIV Netherlands Australia Thailand Research Collaboration.
Who makes Zidovudine, Stavudine, Didanosine, Lamivudine?
Zidovudine, Stavudine, Didanosine, Lamivudine is developed by The HIV Netherlands Australia Thailand Research Collaboration (see full The HIV Netherlands Australia Thailand Research Collaboration pipeline at /company/the-hiv-netherlands-australia-thailand-research-collaboration).
What development phase is Zidovudine, Stavudine, Didanosine, Lamivudine in?
Zidovudine, Stavudine, Didanosine, Lamivudine is in Phase 2.